The webinar is streamed exclusively through the Cvent platform. Registered attendees will receive a secure link to join.
WEBINAR From Guidance to Practice: Navigating Data Integrity Under EU Annex 11, Annex 22 Draft & FDA Regulations
The program spans regulatory interpretation, practical implementation, inspection readiness, and the growing role of AI and Machine Learning in GxP-regulated environments
The integrity of data generated, processed, and stored within GxP-regulated environments sits at the heart of pharmaceutical compliance. As regulatory frameworks continue to evolve — and as digital transformation accelerates across the industry — organisations face mounting pressure to ensure that every data point created throughout the product lifecycle is attributable, legible, contemporaneous, original, and accurate (ALCOA+).
This three-session webinar series, From Guidance to Practice, is designed to bridge the gap between regulatory text and real-world implementation. Drawing on the requirements of EU Annex 11 (Computerised Systems), the newly drafted EU Annex 22 (Management of Data and Records), and the FDA's evolving guidance on data integrity and computer software assurance, the programme offers practitioners a structured, expert-led pathway through the regulatory landscape.
Speakers
Key points
Explain the current requirements under EU Annex 11
Describe the key changes introduced by the Annex 22 Draft
Compare FDA guidance on data integrity against EU frameworks
Highlight compliance implications for industry
Define ALCOA+ and map principles to regulatory expectations
Demonstrate practical implementation in computerised systems
Address hybrid environment challenges
Share real-world examples of data integrity failures and preventive strategies
Understand how AI and automation can proactively identify data integrity risks
Evaluate the key validation requirements for AI monitoring tools in GxP
Design governance frameworks for AI-powered continuous monitoring
Assess tool options and approaches for anomaly detection in audit trails and data flows
Who should attend
Chief Executives, Vice Presidents, Directors, Heads, Leaders, and Managers specializing in:
- Quality Assurance & Quality Systems Managers
- Regulatory Affairs Professionals
- IT, CSV & Computer System Validation Specialists
- Compliance Officers & GxP Auditors
- Manufacturing & Operations Leaders
- Data Scientists & Digital Transformation Teams
- Senior Leaders & Heads of Quality / Compliance
WEBINAR From Guidance to Practice: Navigating Data Integrity Under EU Annex 11, Annex 22 Draft & FDA Regulations
The program spans regulatory interpretation, practical implementation, inspection readiness, and the growing role of AI and Machine Learning in GxP-regulated environments
FAQ
Your questions answered here.
-
STANDARD – Webinar access + digital certificate of attendance.
-
ALL IN ONE – Webinar access + recording + digital certificate of attendance.
-
RECORDING ONLY – Access to the webinar recording via a secure link.
Yes. All in One & Standard packages include attendance provide a digital certificate.
All summit sessions will be presented in English. While translation services are not provided, we welcome attendees from around the world and encourage everyone to join the discussions and networking opportunities.
For any event assistance please contact
Stay informed. Stay ahead
Subscribe to our newsletter for exclusive pharma event updates, industry insights, and speaker announcements.